Patent · US Active

CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases

US10703796B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignees

AMCURE GMBH · DE
RUPRECHT-KARLS-UNIVERSITAT · DE

Inventors

Alexandra MATZKE-OGI · Blankenloch, DE
Véronique Orian-Rousseau · Rittershoffen, FR
Uwe Haberkorn · Schwetzingen, DE
Thomas Lindner · Wiesbaden, DE
Walter Mier · Bensheim, DE

Key dates

Filing date	Dec 7, 2015
Grant date	Jul 7, 2020
Priority date	—
Expiry date	Dec 7, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of cancer and angiogenesis related diseases using cyclic peptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.